ESC BOARD FOR WORKING GROUPS
Vice-President for Working Groups, Associations and Councils
Prof. Adam TORBICKI, FESC (PL)
Adam Torbicki is Professor of Medicine and Head of the Department of Chest Medicine at the Institute of Tuberculosis and Lung Diseases, Warsaw, Poland, a reference centre for pulmonary hypertension and embolism.
He received his medical degree from Warsaw University School of Medicine in 1978. A specialist in Internal Medicine and Cardiology, Dr Torbicki has held fellowships at the University of Freiburg, Freiburg, Germany and University of Pavia, Pavia, Italy.
Since 1982, Dr Torbicki has been involved in research related to pulmonary circulation, with a special interest in non-invasive evaluation of pulmonary haemodynamics and right ventricular function. He has contributed to many recent trials assessing pharmacologic treatments in pulmonary hypertension and is the coordinator of the task force preparing an update of the first European Guidelines on Diagnosis and Treatment of Pulmonary Embolism, which was originally published in 2000.Dr Torbicki was Chairman of the Organizing Committee of the Pulmonary Circulation European Forum in Warsaw in 2006, Chairman of the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology from 2004 to 2006, and has been President of the Polish Cardiac Society since 2004.
Councillor for Working Groups
Prof. Martin BORGGREFE, FESC (DE)
Martin Borggrefe is Professor of Cardiology and the Director of the Department of Cardiology, I. University Hospital Mannheim, Ruprecht-Karls-University of Heidelberg, Germany.
Prof. Borggrefe received his medical degree at the University of Düsseldorf, Germany, in 1980. From 1988-1988 he had a fellowship at the Department of Internal Medicine at the University of Düsseldorf, and from 1989-2000 he was an Assistant Professor and the Director of Electrophysiology at the Department of Internal Medicine, University Münster, Germany. From 2000-2001 he was the Director of the Department of Cardiology and Angiology, II. University Hospital Mannheim, Ruprecht-Karls-University of Heidelberg, Germany, and in April 2001 he received his current position as the Director of the Department of Cardiology, I. University Hospital Mannheim, Ruprecht-Karls-University of Heidelberg, Germany.
Prof. Borggrefe’s research interests focus on diagnostics and therapy of cardiac arrhythmias, cardiomyopathies, the clinical manifestation of atherosclerosis, and mechanisms, diagnostics and therapy of cardiac insufficiency and heart failures.
Trials for which Prof. Borggrefe is, or has been, principal investigator include the SHock Inhibition Evaluation with Azimilide (SHIELD) study, the European Powerheart study, and the Ventricular Arrhythmias Dofetilide study. Dr Borggrefe is a member of the Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology and of the Steering Committee of the Unexplained Cardiac Arrest Registry of Europe (UCARE). He is an Editorial Board member of the Journal of Cardiovascular Electrophysiology. He was awarded with Fritz-Acker Prize of the German Society of Cardiology, and the Hannelore Stübler Prize of the Society of Cardiovascular System Research Essen in 2002
Prof. Borggrefe’s publications include over 350 papers and abstracts on cardiovascular disease in journals such as Heart Rhythm, Circulation, the American Journal of Cardiology, Heart, the European Heart Journal, Lancet, the American Heart Journal, Cardiovascular Research, Cerebrovascular Diseases, Nature, and the British Heart Journal. Prof. Borggrefe has contributed to several books about the pathophysiology, diagnosis and management of cardiovascular disease.